301 related articles for article (PubMed ID: 24673568)
21. Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
An M; Liu H
Small; 2017 Jul; 13(26):. PubMed ID: 28544329
[TBL] [Abstract][Full Text] [Related]
22. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
[TBL] [Abstract][Full Text] [Related]
23. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
24. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous vaccination with coated microneedles prevents development of airway allergy.
Shakya AK; Lee CH; Gill HS
J Control Release; 2017 Nov; 265():75-82. PubMed ID: 28821461
[TBL] [Abstract][Full Text] [Related]
26. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery.
Garland MJ; Caffarel-Salvador E; Migalska K; Woolfson AD; Donnelly RF
J Control Release; 2012 Apr; 159(1):52-9. PubMed ID: 22265694
[TBL] [Abstract][Full Text] [Related]
27. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design.
Chen MC; Lai KY; Ling MH; Lin CW
Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028
[TBL] [Abstract][Full Text] [Related]
28. Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.
Zhao JH; Zhang QB; Liu B; Piao XH; Yan YL; Hu XG; Zhou K; Zhang YT; Feng NP
Int J Nanomedicine; 2017; 12():4763-4772. PubMed ID: 28740383
[TBL] [Abstract][Full Text] [Related]
29. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y
Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987
[TBL] [Abstract][Full Text] [Related]
30. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
[TBL] [Abstract][Full Text] [Related]
31. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.
Zaric M; Lyubomska O; Touzelet O; Poux C; Al-Zahrani S; Fay F; Wallace L; Terhorst D; Malissen B; Henri S; Power UF; Scott CJ; Donnelly RF; Kissenpfennig A
ACS Nano; 2013 Mar; 7(3):2042-55. PubMed ID: 23373658
[TBL] [Abstract][Full Text] [Related]
32. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery.
Mönkäre J; Reza Nejadnik M; Baccouche K; Romeijn S; Jiskoot W; Bouwstra JA
J Control Release; 2015 Nov; 218():53-62. PubMed ID: 26437262
[TBL] [Abstract][Full Text] [Related]
33. Rapidly dissolving bilayer microneedle arrays - A minimally invasive transdermal drug delivery system for vitamin B12.
Ramöller IK; Tekko IA; McCarthy HO; Donnelly RF
Int J Pharm; 2019 Jul; 566():299-306. PubMed ID: 31150773
[TBL] [Abstract][Full Text] [Related]
34. Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice.
van der Maaden K; Varypataki EM; Romeijn S; Ossendorp F; Jiskoot W; Bouwstra J
Eur J Pharm Biopharm; 2014 Oct; 88(2):310-5. PubMed ID: 24820032
[TBL] [Abstract][Full Text] [Related]
35. In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles.
Kennedy J; Larrañeta E; McCrudden MTC; McCrudden CM; Brady AJ; Fallows SJ; McCarthy HO; Kissenpfennig A; Donnelly RF
J Control Release; 2017 Nov; 265():57-65. PubMed ID: 28428065
[TBL] [Abstract][Full Text] [Related]
36. Engineering of an automated nano-droplet dispensing system for fabrication of antigen-loaded dissolving microneedle arrays.
Lee J; van der Maaden K; Gooris G; O'Mahony C; Jiskoot W; Bouwstra J
Int J Pharm; 2021 May; 600():120473. PubMed ID: 33737094
[TBL] [Abstract][Full Text] [Related]
37. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
38. A surface charge dependent enhanced Th1 antigen-specific immune response in lymph nodes by transfersome-based nanovaccine-loaded dissolving microneedle-assisted transdermal immunization.
Wu X; Li Y; Chen X; Zhou Z; Pang J; Luo X; Kong M
J Mater Chem B; 2019 Aug; 7(31):4854-4866. PubMed ID: 31389952
[TBL] [Abstract][Full Text] [Related]
39. Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches.
Anjani QK; Sabri AHB; Utomo E; Domínguez-Robles J; Donnelly RF
Mol Pharm; 2022 Apr; 19(4):1191-1208. PubMed ID: 35235330
[TBL] [Abstract][Full Text] [Related]
40. Dissolving microneedles: Applications and growing therapeutic potential.
Sartawi Z; Blackshields C; Faisal W
J Control Release; 2022 Aug; 348():186-205. PubMed ID: 35662577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
